Alpha Dna Investment Management LLC Supernus Pharmaceuticals, Inc. Transaction History
Alpha Dna Investment Management LLC
- $261 Million
- Q3 2024
Shares
3 transactions
Others Institutions Holding SUPN
# of Institutions
285Shares Held
60.7MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$388 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$229 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$190 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$108 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$98.3 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...